相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
Peng Cao et al.
FRONTIERS IN IMMUNOLOGY (2022)
Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management
Anastasiya Muntyanu et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2021)
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
S. Morteza Seyed Jafari et al.
FRONTIERS IN IMMUNOLOGY (2021)
Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
Si-Hang Wang et al.
FRONTIERS IN IMMUNOLOGY (2021)
A Novel Germline Heterozygous BCL11B Variant Causing Severe Atopic Disease and Immune Dysregulation
Henry Y. Lu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
Yihua Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature
Aikaterini Tsiogka et al.
ACTA DERMATO-VENEREOLOGICA (2021)
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
Dedee F. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Pathophysiologic mechanisms of itch in bullous pemphigoid
Takashi Hashimoto et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series
Rana Abdat et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients
Maxim Polansky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid
S. Morteza Seyed Jafari et al.
FRONTIERS IN IMMUNOLOGY (2019)
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
David J. Pinato et al.
JAMA ONCOLOGY (2019)
Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature
Noa Kremer et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Nivolumab-induced bullous pemphigoid after radiotherapy and abscopal effect
Xavier Grimaux et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2019)
Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid
Alyson V. Ridpath et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors
Adriana T. Lopez et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management
Kyle T. Amber et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid
Laura Sowerby et al.
JAMA DERMATOLOGY (2017)
Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
Zuo-Tao Zhao et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
Patrick J. Medina et al.
PHARMACOTHERAPY (2016)
Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens
Hsiao-Han Wang et al.
ACTA DERMATO-VENEREOLOGICA (2015)
First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
Y. T. Cho et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
C. Feliciani et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid
K. A. N. Messingham et al.
IMMUNOLOGIC RESEARCH (2014)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012
V. A. Venning et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Corticosteroid Use in Autoimmune Blistering Diseases
John W. Frew et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2012)
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Dedee F. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Selective Ablation of Ctip2/Bcl11b in Epidermal Keratinocytes Triggers Atopic Dermatitis-Like Skin Inflammatory Responses in Adult Mice
Zhixing Wang et al.
PLOS ONE (2012)
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective
Pashtoon M. Kasi et al.
CRITICAL CARE (2012)
Evidence-Based Management of Bullous Pemphigoid
Benjamin S. Daniel et al.
DERMATOLOGIC CLINICS (2011)
Clinical Features and Practical Diagnosis of Bullous Pemphigoid
Enno Schmidt et al.
DERMATOLOGIC CLINICS (2011)
Evidence-based treatments for pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid: A systematic review
Sanjay Singh
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2011)
Interventions for bullous pemphigoid
Gudula Kirtschig et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
B Cells and Immunological Tolerance
Nataly Manjarrez-Orduno et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study
Pascal Joly et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid
P Joly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
